Lavinso Antifungal
NDC Package 87011-102-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lavinso Antifungal is wash affected area and dry thoroughlyApply a thin layer of the product over affected area twice daily (morning and night)For athlete's foot and ringworm: use daily for 4 weeksFor jock itch and ringworm: use daily for 2 weeksTo prevent athlete's foot, apply once or twice dailyPay special attention to spaces between toesWear well-fitting, ventilated shoes and change socks at least once daily. Marketed by Lavinso Trading Llc, this product is identified by NDC 87011-102 and is authorized under FDA application M005.

Identification & Billing

NDC Package Code
87011-102-01
Package Description
232 g in 1 CARTON
Product Code
87011-102
11-Digit Billing Format
87011010201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lavinso Antifungal
Dosage Form
-
Usage Information
Wash affected area and dry thoroughlyApply a thin layer of the product over affected area twice daily (morning and night)For athlete's foot and ringworm: use daily for 4 weeksFor jock itch and ringworm: use daily for 2 weeksTo prevent athlete's foot, apply once or twice dailyPay special attention to spaces between toesWear well-fitting, ventilated shoes and change socks at least once daily

Regulatory & Marketing

Labeler Name
Lavinso Trading Llc
FDA Application #
M005
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-12-2025
Listing Expiration
12-31-2026
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87011-102-01 identifies a specific commercial package of 232 g in 1 carton of Lavinso Antifungal, labeled by Lavinso Trading Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Lavinso Trading Llc on December 12, 2025. The current certification is valid through December 31, 2026.

How is this Lavinso Trading Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87011010201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87011-102-01
11-Digit CMS (5-4-2)
87011-0102-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.